Apimeds Pharmaceuticals US (APUS) vs Chemomab Therapeutics (CMMB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Apimeds Pharmaceuticals US (APUS) has outperformed Chemomab Therapeutics (CMMB) over the past year, losing 58.8% versus a loss of 60.7%. Apimeds Pharmaceuticals US is the larger company by market cap ($10.6 million vs $10.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | APUS | CMMB |
|---|---|---|
| Share price | $7.05 | $1.37 |
| Market cap | $10.64M | $10.04M |
| 1-day change | -1.12% | -2.14% |
| YTD return | -57.01% | -16.97% |
| 1-year return | -58.77% | -60.69% |
| 5-year return | — | -96.23% |
| EPS (TTM) | $-36.03 | $-1.04 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $59.70 | $3.55 |
| 52-week low | $1.51 | $1.05 |
| Distance from 52-week high | -88.19% | -61.41% |
| Average volume | 3.36M | 152.77K |
| Shares outstanding | 1.51M | 7.33M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
APUS vs CMMB FAQ
Which is bigger, Apimeds Pharmaceuticals US or Chemomab Therapeutics?
Apimeds Pharmaceuticals US (APUS) is larger, with a market capitalization of $10.64M compared with $10.04M for Chemomab Therapeutics (CMMB).
Which stock has performed better over the past year, APUS or CMMB?
APUS returned -58.77% over the past 12 months, compared with -60.69% for CMMB (price return, excluding dividends). Past performance does not predict future results.
Are Apimeds Pharmaceuticals US and Chemomab Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.